CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

BlueCross BlueShield of Arkansas

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
108.5
Vs. acquisition
+5.6%
Brand index
108.5
Biosimilar index
133.4
Contract variability
Low
Drugs observed
917
States
21

Contracts above the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 96% of billing volume on the single most common rate — an effectively posted price.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.